CRLS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.530600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.567000E-01
Normal-vs-Stage2
4.875600E-01
Normal-vs-Stage3
5.305200E-01
Normal-vs-Stage4
6.300200E-01
Stage1-vs-Stage2
7.064200E-01
Stage1-vs-Stage3
2.704200E-01
Stage1-vs-Stage4
8.287400E-01
Stage2-vs-Stage3
1.303980E-01
Stage2-vs-Stage4
9.531000E-01
Stage3-vs-Stage4
2.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.659200E-01
Normal-vs-AfricanAmerican
4.845200E-01
Normal-vs-Asian
3.611600E-01
Caucasian-vs-AfricanAmerican
9.228400E-01
Caucasian-vs-Asian
5.740600E-01
AfricanAmerican-vs-Asian
7.441200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.539400E-01
Normal-vs-Female
5.601400E-01
Male-vs-Female
5.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.459200E-01
Normal-vs-Age(41-60Yrs)
4.409600E-01
Normal-vs-Age(61-80Yrs)
6.089400E-01
Normal-vs-Age(81-100Yrs)
4.972200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.299240E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.409800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.197200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.371000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.195800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.947600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.713200E-01
Normal-vs-Daily Drinker
6.576200E-01
Normal-vs-Weekly Drinker
3.271400E-01
Normal-vs-Occasional Drinker
3.880800E-01
Normal-vs-Social Drinker
5.978400E-01
Non Drinker-vs-Daily Drinker
9.061800E-01
Non Drinker-vs-Weekly Drinker
4.498200E-01
Non Drinker-vs-Occasional Drinker
7.716600E-01
Non Drinker-vs-Social Drinker
9.437200E-01
Daily Drinker-vs-Weekly Drinker
4.487800E-01
Daily Drinker-vs-Occasional Drinker
7.141800E-01
Daily Drinker-vs-Social Drinker
8.767400E-01
Weekly Drinker-vs-Occasional Drinker
5.940400E-01
Weekly Drinker-vs-Social Drinker
5.712000E-01
Occasional Drinker-vs-Social Drinker
8.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.554800E-01
Normal-vs-Grade 2
7.986200E-01
Normal-vs-Grade 3
4.909600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.278370E-01
Grade 1-vs-Grade 3
2.113600E-01
Grade 1-vs-Grade 4
7.554800E-01
Grade 2-vs-Grade 3
9.617200E-01
Grade 2-vs-Grade 4
7.986200E-01
Grade 3-vs-Grade 4
4.909600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.352200E-01
Normal-vs-NonDiabetic
4.949200E-01
Diabetic-vs-NonDiabetic
1.976370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.758600E-01
Normal-vs-NoPancreatitis
5.410800E-01
Pancreatitis-vs-NoPancreatitis
3.494600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.358800E-01
Normal-vs-N1
4.872200E-01
N0-vs-N1
2.923400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.420000E-01
Normal-vs-TP53-NonMutant
7.251000E-01
TP53-Mutant-vs-TP53-NonMutant
7.023500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
